New coronavirus leaves pregnant women with wrenching choices—but little data to guide them
Parents and doctors must decide whether the benefits of breastfeeding outweigh the risks of possible infection
Coronavirus
Read our COVID-19 research and news.
-
-
How sick will the coronavirus make you? The answer may be in your genes
Projects drawing on large biobanks and COVID-19 patients aim to find genetic differences that predict who will get seriously ill after an infection -
Podcast: Why some diseases come and go with the seasons, and how to develop smarter, safer chemicals
On this week’s show: An update on the coronavirus pandemic, understanding why diseases wax and wane with the seasons, and the movement to utilize new tools to test the safety of chemicals -
Congress pumps up NSF program to fast-track COVID-19 research
Stimulus gives National Science Foundation $75 million to expand rarely used RAPID grants -
‘This is insane!’ Many scientists lament Trump’s embrace of risky malaria drugs for coronavirus
Small French study that led to huge demand for hydroxychloroquine and chloroquine comes under heavy fire -
The new coronavirus is finally slamming Russia. Is the country ready?
After initial reprieve, COVID-19 cases are rising and filling hospital wards, virologist says -
How diseases rise and fall with the seasons—and what it could mean for coronavirus
Scientists look at seasonal changes to the environment—and our own immune systems -
Mathematics of life and death: How disease models shape national shutdowns and other pandemic policies
The coronavirus highlights the “huge responsibility” of infectious disease modelers -
Science-ing from home isn’t easy. Our humor columnist shares his tips
“Watch talks on YouTube and pretend that visiting scientists are giving lectures in your living room” -
Massive U.S. coronavirus stimulus includes research dollars and some aid to universities
NIH would get nearly $1 billion; NSF would have $75 million more for emergency field studies -
Meet the company that has just begun testing a coronavirus vaccine in the United States
Science visited Moderna in 2017 for an early look at its innovative RNA-based technology for drugs and vaccines -
Researchers are tracking another pandemic, too—of coronavirus misinformation
Ironically, the spread of false information often reflects a desire to help -
‘It’s heartbreaking.’ Labs are euthanizing thousands of mice in response to coronavirus pandemic
Universities mandate or encourage rodent euthanasia to save resources and protect staff -
Can a century-old TB vaccine steel the immune system against the new coronavirus?
Scientists launch trial of bacillus Calmette-Guérin, a vaccine made of living bacteria, to protect health care workers at risk of COVID-19 infection -
‘I’m going to keep pushing.’ Anthony Fauci tries to make the White House listen to facts of the pandemic
The infectious disease researcher has become the United States’s most trusted coronavirus expert -
WHO launches global megatrial of the four most promising coronavirus treatments
Simple design aims to let even overwhelmed physicians and hospitals participate
